Mice with liver-specific TRPC3 silencing manifested mild fatty liver and exacerbated liver pathologies of ALD upon chronic alcohol consumption, whereas genetic replenishment of hepatic TRPC3 ameliorated ALD development. This evidence concerns the gene TRPC3 and fatty liver disease.